Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats
ABSTRACT Neutrophil infiltration has been reported to play an important role in spinal cord injury (SCI). In addition to their cardioprotective effects, beta-blockers have been found to have neuroprotective effects on the central nervous system, but their effect on SCI has not yet been studied. In the current study, we investigated the effect of metoprolol on myeloperoxidase (MPO) activity, a marker of neutrophil activation, in the spinal cord after experimental SCI in rats. Rats were divided into six groups: controls received only laminectomy and spinal cord samples were taken immediately; the sham operated group received laminectomy, and spinal cord samples were taken 4h after laminectomy; the trauma only group underwent a 50g/cm contusion injury but received no medication; and three other groups underwent trauma as for the trauma group, and received 30mg/kg methylprednisolone, 1mg/kg metoprolol, or 1mL saline, respectively. All the medications were given intraperitoneally as single doses, immediately after trauma. Spinal cord samples were taken 4h after trauma and studied for MPO activity. The results showed that tissue MPO activity increased after injury. Both metoprolol and methylprednisolone treatments decreased MPO activity, indicating a reduction in neutrophil infiltration in damaged tissue. The effect of metoprolol on MPO activity was found to be similar to methylprednisolone. In view of these data, we conclude that metoprolol may be effective in protecting rat spinal cord from secondary injury.
- SourceAvailable from: Andrew David Gaudet
[Show abstract] [Hide abstract]
- "How to accomplish this is less obvious. On the one hand, methods to deplete or inhibit leukocyte functions can be neuroprotective and improve recovery, especially if the intervention is started early after trauma (Beril et al., 2007; Blight, 1994; Busch et al., 2009; Eng and Lee, 2003; Giulian and Robertson, 1990; Gris et al., 2004; Noble et al., 2002; Popovich et al., 1999). However, these same cells can enhance repair and disrupting the normal composition or dynamics of acute inflammation could have unwanted long-term consequences (Rapalino et al., 1998; Shechter and Schwartz, 2013; Stirling et al., 2009). "
ABSTRACT: Throughout the body, the extracellular matrix (ECM) provides structure and organization to tissues and also helps regulate cell migration and intercellular communication. In the injured spinal cord (or brain), changes in the composition and structure of the ECM undoubtedly contribute to regeneration failure. Less appreciated is how the native and injured ECM influences intraspinal inflammation and, conversely, how neuroinflammation affects the synthesis and deposition of ECM after CNS injury. In all tissues, inflammation can be initiated and propagated by ECM disruption. Molecules of ECM newly liberated by injury or inflammation include hyaluronan fragments, tenascins, and sulfated proteoglycans. These act as “damage-associated molecular patterns” or “alarmins”, i.e., endogenous proteins that trigger and subsequently amplify inflammation. Activated inflammatory cells, in turn, further damage the ECM by releasing degradative enzymes including matrix metalloproteinases (MMPs). After spinal cord injury (SCI), destabilization or alteration of the structural and chemical compositions of the ECM affects migration, communication, and survival of all cells – neural and non-neural – that are critical for spinal cord repair. By stabilizing ECM structure or modifying their ability to trigger the degradative effects of inflammation, it may be possible to create an environment that is more conducive to tissue repair and axon plasticity after SCI.Experimental Neurology 08/2014; 258. DOI:10.1016/j.expneurol.2013.11.020 · 4.62 Impact Factor
[Show abstract] [Hide abstract]
- "Through the release of cytokines and other factors, inflammatory cell populations such as neutrophils and macrophages have long been associated with CNS toxicity (Bao and Liu, 2002; Chao et al., 1992; Donnelly and Popovich, 2008; Shamash et al., 2002). Various groups have further demonstrated that attenuation of these inflammatory mediators is beneficial and promotes neurological recovery (Beril et al., 2007; Blight, 1994; Giulian and Robertson, 1990; Gris et al., 2004; Pannu et al., 2005; Popovich et al., 1999). However, it has also been suggested that inflammation may play a dual role in neural recovery and may have significant beneficial aspects. "
ABSTRACT: A robust and complex inflammatory cascade is known to be a prominent component of secondary injury following spinal cord injury (SCI). Specifically, the concept of trauma-induced autoimmunity has linked the lymphocyte population with neural tissue injury and neurologic deficit. FTY720, a sphingosine receptor modulator that sequesters lymphocytes in secondary lymphoid organs, has been shown to be effective in the treatment of a variety of experimental autoimmune disorders. Accordingly, by reducing lymphocyte infiltration into the spinal cord following SCI, this novel immunomodulator may enhance tissue preservation and functional recovery. In the present study, a moderate to severe contusion SCI was simulated in adult Long-Evans hooded rats. Using flow cytometry we showed that daily FTY720 treatment dramatically reduced T-cell infiltration into the SCI lesion site at 4 and 7 days post-injury, while other inflammatory cell populations were relatively unaltered. To assess functional recovery, three groups of injured animals (treated, vehicle, and injury only) were evaluated weekly for hindlimb recovery. Animals in the treated group consistently exhibited higher functional scores than animals in the control groups after 2 weeks post-injury. This finding was associated with a greater degree of white matter sparing at the lesion epicenter when cords were later sectioned and stained. Furthermore, treated animals were found to exhibit improved bladder function and a reduced incidence of hemorrhagic cystitis compared to control counterparts. Collectively these results demonstrate the neuroprotective potential of FTY720 treatment after experimental SCI.Journal of neurotrauma 08/2009; 26(12):2335-44. DOI:10.1089/neu.2008.0840 · 3.97 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Trauma to the central nervous system (CNS) triggers intraparenchymal inflammation and activation of systemic immunity with the capacity to exacerbate neuropathology and stimulate mechanisms of tissue repair. Despite our incomplete understanding of the mechanisms that control these divergent functions, immune-based therapies are becoming a therapeutic focus. This review will address the complexities and controversies of post-traumatic neuroinflammation, particularly in spinal cord. In addition, current therapies designed to target neuroinflammatory cascades will be discussed.Experimental Neurology 03/2008; 209(2):378-88. DOI:10.1016/j.expneurol.2007.06.009 · 4.62 Impact Factor